Bank of America’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-283,416
| Closed | -$13.3M | – | 8671 |
|
|
2025
Q2 | $13.3M | Sell |
283,416
-539,390
| -66% | -$24M | ﹤0.01% | 2954 |
|
|
2025
Q1 | $36.3M | Buy |
822,806
+405,918
| +97% | +$18.7M | ﹤0.01% | 1876 |
|
|
2024
Q4 | $15.1M | Sell |
416,888
-444,322
| -52% | -$15.5M | ﹤0.01% | 2554 |
|
|
2024
Q3 | $27.6M | Buy |
861,210
+74,314
| +9% | +$2.78M | ﹤0.01% | 2092 |
|
|
2024
Q2 | $29.6M | Sell |
786,896
-238,936
| -23% | -$10.1M | ﹤0.01% | 1874 |
|
|
2024
Q1 | $50.5M | Buy |
1,025,832
+670,484
| +189% | +$31M | ﹤0.01% | 1471 |
|
|
2023
Q4 | $13M | Sell |
355,348
-393,932
| -53% | -$10.3M | ﹤0.01% | 2598 |
|
|
2023
Q3 | $17.3M | Sell |
749,280
-1,083,821
| -59% | -$29.6M | ﹤0.01% | 2190 |
|
|
2023
Q2 | $48.1M | Sell |
1,833,101
-85,861
| -4% | -$2.26M | 0.01% | 1334 |
|
|
2023
Q1 | $49.4M | Buy |
1,918,962
+123,559
| +7% | +$3.61M | 0.01% | 1377 |
|
|
2022
Q4 | $46.7M | Buy |
1,795,403
+85,627
| +5% | +$2.11M | 0.01% | 1353 |
|
|
2022
Q3 | $48.8M | Buy |
1,709,776
+63,433
| +4% | +$1.82M | 0.01% | 1277 |
|
|
2022
Q2 | $40.5M | Buy |
1,646,343
+18,856
| +1% | +$690K | ﹤0.01% | 1416 |
|
|
2022
Q1 | $91.9M | Buy |
1,627,487
+113,114
| +7% | +$6.47M | 0.01% | 1005 |
|
|
2021
Q4 | $93.9M | Buy |
1,514,373
+374,608
| +33% | +$24.8M | 0.01% | 1032 |
|
|
2021
Q3 | $72.3M | Buy |
1,139,765
+367,303
| +48% | +$28.3M | 0.01% | 1133 |
|
|
2021
Q2 | $63.7M | Buy |
772,462
+271,908
| +54% | +$20.6M | 0.01% | 1211 |
|
|
2021
Q1 | $36.8M | Buy |
500,554
+493,485
| +6,981% | +$38.6M | ﹤0.01% | 1528 |
|
|
2020
Q4 | $512K | Sell |
7,069
-22
| -0.3% | -$1.42K | ﹤0.01% | 4994 |
|
|
2020
Q3 | $338K | Sell |
7,091
-2,639
| -27% | -$112K | ﹤0.01% | 4984 |
|
|
2020
Q2 | $409K | Buy |
9,730
+7,174
| +281% | +$255K | ﹤0.01% | 4762 |
|
|
2020
Q1 | $69K | Buy |
2,556
+898
| +54% | +$29.3K | ﹤0.01% | 5718 |
|
|
2019
Q4 | $64K | Buy |
+1,658
| New | +$38.8K | ﹤0.01% | 6177 |
|
Other funds holding SWTX
Bank of America's SWTX Position: Q3 2025 in Review
Bank of America sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 283,416 shares — an estimated $13.3M sold.
Bank of America first reported a position in SWTX in Q4 2019 and held it in 23 quarters. The position peaked at $93.9M in Q4 2021. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- Bank of America reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- Bank of America sold 283,416 SpringWorks Therapeutics shares in Q3 2025, an estimated $13.3M.
- Bank of America first reported a position in SpringWorks Therapeutics in Q4 2019 and held it in 23 quarters.
- Bank of America's SpringWorks Therapeutics position peaked at $93.9M in Q4 2021.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.